Bcl-2 | Community Health

Bcl-2, a protein encoded by the BCL2 gene, is a crucial regulator of programmed cell death, or apoptosis. As the founding member of the Bcl-2 family, it has been extensively studied for its role in blocking apoptosis, while other family members can either inhibit or induce it. With its discovery in B-cell lymphoma 2, Bcl-2 has become a significant area of research in understanding cancer development and treatment. The Bcl-2 family, including proteins like [[bcl-3|BCL3]], [[bcl-6|BCL6]], and [[bcl-10|BCL10]], has been implicated in various types of lymphoma, highlighting the importance of Bcl-2 in cell survival and death. According to the [[national-cancer-institute|National Cancer Institute]], dysregulation of Bcl-2 has been observed in approximately 50% of follicular lymphoma cases, making it a promising target for therapeutic intervention. With ongoing research, the understanding of Bcl-2's function and its potential applications in cancer treatment continue to evolve, as seen in studies published in the [[journal-of-clinical-oncology|Journal of Clinical Oncology]] and the [[new-england-journal-of-medicine|New England Journal of Medicine]].